Hosier, G. W., & Touma, N. J. (2017). Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia. Canadian Urological Association Journal, 11(5), E237–9. https://doi.org/10.5489/cuaj.4316